Israel Englander Abbott Laboratories Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Millennium Management LLC holds 2,328,311 shares of ABT stock, worth $272 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,328,311

Previous 619,529 275.82%

Holding current value

$272 Million

Previous $70.4 Million 243.58%

% of portfolio

0.12%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $172 Million - $192 Million	1,708,782 Added 275.82%	2,328,311 $242 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $28.8 Million - $31.8 Million	263,010 Added 73.77%	619,529 $70.4 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $32.4 Million - $39.7 Million	-359,708 Reduced 50.22%	356,519 $39.2 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $10.6 Million - $11.9 Million	-105,576 Reduced 12.85%	716,227 $78.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $79.6 Million - $93.7 Million	821,803 New	821,803 $83.2 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $129 Million - $149 Million	-1,334,413 Reduced 51.45%	1,259,182 $122 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $2.44 Million - $2.94 Million	23,869 Added 0.93%	2,593,595 $282 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $188 Million - $230 Million	1,650,980 Added 179.7%	2,569,726 $304 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $30.8 Million - $37.8 Million	266,944 Added 40.95%	918,746 $129 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $49.7 Million - $55 Million	-426,093 Reduced 39.53%	651,802 $77 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $1.77 Million - $2.09 Million	-16,744 Reduced 1.53%	1,077,895 $125 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $39.2 Million - $46.2 Million	-360,528 Reduced 24.78%	1,094,639 $131 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $47.5 Million - $51.7 Million	451,970 Added 45.05%	1,455,167 $159 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $40 Million - $48.6 Million	436,277 Added 76.96%	1,003,197 $109 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $32.6 Million - $41.8 Million	426,168 Added 302.78%	566,920 $51.8 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $4.2 Million - $6.15 Million	-66,900 Reduced 32.22%	140,752 $11.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $5.3 Million - $5.9 Million	-67,462 Reduced 24.52%	207,652 $18 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $9.97 Million - $10.8 Million	-121,800 Reduced 30.69%	275,114 $23 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $28.3 Million - $33 Million	388,362 Added 4541.18%	396,914 $4.26 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $217 Million - $240 Million	-3,773,584 Reduced 99.77%	8,552 $522,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $52.1 Million - $58.9 Million	-926,384 Reduced 19.67%	3,782,136 $227 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $251 Million - $269 Million	4,681,343 Added 17225.39%	4,708,520 $269 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $1.31 Million - $1.46 Million	27,177	27,177 $1.45 Million

Others Institutions Holding ABT

# of Institutions

3,177

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account